Based on the Aeolus Pharmaceuticl stock forecast from 0 analysts, the average analyst target price for Aeolus Pharmaceuticl is not available over the next 12 months. Aeolus Pharmaceuticl’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aeolus Pharmaceuticl is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Aeolus Pharmaceuticl’s stock price was USD 0.00. Aeolus Pharmaceuticl’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +200.00% over the last year.
No recent analyst target price found for Aeolus Pharmaceuticl
No recent average analyst rating found for Aeolus Pharmaceuticl
Company Overview Aeolus Pharmaceuticl
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Read Less
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as me...Read More
Frequently Asked Questions About Aeolus Pharmaceuticl (AOLS) Stock
Stock Target Advisor's fundamental analysis for Aeolus Pharmaceuticl's stock is Very Bearish.
Unfortunately we do not have enough data on AOLS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AOLS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AOLS's stock to indicate if its overvalued.
The last closing price of AOLS's stock was USD 0.00.
The most recent market capitalization for AOLS is USD 0.17M.
Unfortunately we do not have enough analyst data on AOLS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aeolus Pharmaceuticl's stock.
As per our most recent records Aeolus Pharmaceuticl has 4 Employees.
Aeolus Pharmaceuticl's registered address is 26361 Crown Valley Parkway, Mission Viejo, CA, United States, 92691.
You can get more information about it from Aeolus Pharmaceuticl's website at https://www.aeoluspharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Aeolus Pharmaceuticl (AOLS) Stock
Stock Target Advisor's fundamental analysis for Aeolus Pharmaceuticl's stock is Very Bearish.
Unfortunately we do not have enough data on AOLS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AOLS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AOLS's stock to indicate if its overvalued.
The last closing price of AOLS's stock was USD 0.00.
The most recent market capitalization for AOLS is USD 0.17M.
Unfortunately we do not have enough analyst data on AOLS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aeolus Pharmaceuticl's stock.
As per our most recent records Aeolus Pharmaceuticl has 4 Employees.
Aeolus Pharmaceuticl's registered address is 26361 Crown Valley Parkway, Mission Viejo, CA, United States, 92691.
You can get more information about it from Aeolus Pharmaceuticl's website at https://www.aeoluspharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AOLS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
